EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Intravenous immunoglobulin and febrile status epilepticus in children with Dravet syndrome: A retrospective multicentre study

Romane Marc iD, Nicole Chemaly, Mathieu Kuchenbuch, Caroline Espil-Taris, Elodie Lametery, Hélène Maurey, Sylviane Peudenier, Sylvie Nguyen The Tich iD, Rima Nabbout, Claire Bar iD

Developmental Medicine & Child Neurology · 2025

DOI: 10.1111/dmcn.70077 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Developmental Medicine & Child Neurology, 2025. Verfasst von Romane Marc und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Neurology, Reference Centre for Rare Epilepsies, CHU Bordeaux, Bordeaux, France. Hauptthemen laut MEDLINE: Immunoglobulins, Intravenous, Status Epilepticus, Epilepsies, Myoclonic, Seizures, Febrile. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To assess the efficacy and tolerability of intravenous immunoglobulin (IVIG) in reducing febrile status epilepticus in children with Dravet syndrome.

Method

We conducted a retrospective multicentre study across seven French university hospitals (2005–2022). Children with genetically confirmed Dravet syndrome who received sequential IVIG were included. Clinical data were collected over two 6‐month periods: before and after IVIG initiation.

Results

Fourteen individuals (six males, eight females) were included. At IVIG initiation, all were in the stormy phase, aged 10 to 92 months, and receiving a median of four antiseizure medications. IVIG was administered every 1 to 6 weeks (0.3–0.5 g/kg per infusion). Hospitalizations for status epilepticus significantly decreased, from a median of 4 (range 0–16) at baseline to 1 (range 0–6) after treatment ( p = 0.002). Twelve individuals improved, two remained stable. Adverse events occurred in 6 out of 14 individuals, including infusion‐related fever or seizures. Central venous access was required in six cases. IVIG was continued beyond 6 months in 11 out of 14 individuals.

Interpretation

These series suggest a potential benefit of IVIG in reducing status epilepticus in selected children with Dravet syndrome. However, tolerability and feasibility issues were identified. A prospective controlled trial is warranted to further define the role of IVIG in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulins, IntravenousStatus EpilepticusEpilepsies, MyoclonicSeizures, FebrileImmunologic FactorsHumansMaleFemaleRetrospective StudiesChild, PreschoolInfantChildTreatment OutcomeAnticonvulsants

Substanzen

Immunoglobulins, IntravenousAnticonvulsantsImmunologic Factors

Autor:innen und Institutionen

  • Department of Paediatric Neurology, Reference Centre for Rare Epilepsies, CHU Bordeaux, Bordeaux, France.
  • Department of Paediatric Neurology, Reference Centre for Rare Epilepsies, Enfants Malades University Hospital, AP-HP, Université Paris Cité, Paris, France.
  • Université de Lorraine, CHRU-Nancy, Service de Pédiatrie, Reference Centre for Rare Epilepsies, Nancy, France.
  • Université de Lorraine, IMoPA, Nancy, France.
  • Department of Paediatric Neurology, Grenoble University Hospital, Grenoble, France.
  • Department of Paediatric Neurology, Competence Centre for Rare Epilepsies, CHU Bicêtre, Le Kremlin Bicêtre, France.

ORCID-Profile: Romane Marc, Sylvie Nguyen The Tich, Claire Bar

Zitieren

APA

Marc, R., Chemaly, N., Kuchenbuch, M., Espil-Taris, C., Lametery, E., Maurey, H., Peudenier, S., Nguyen The Tich, S., Nabbout, R., & Bar, C. (2025). Intravenous immunoglobulin and febrile status epilepticus in children with Dravet syndrome: A retrospective multicentre study. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.70077

Vancouver

Marc R, Chemaly N, Kuchenbuch M, Espil-Taris C, Lametery E, Maurey H, et al. Intravenous immunoglobulin and febrile status epilepticus in children with Dravet syndrome: A retrospective multicentre study. Developmental Medicine & Child Neurology. 2025. doi:10.1111/dmcn.70077

BibTeX
@article{Marc2025,
  author = {Marc, Romane and Chemaly, Nicole and Kuchenbuch, Mathieu and Espil-Taris, Caroline and Lametery, Elodie and Maurey, Hélène and Peudenier, Sylviane and Nguyen The Tich, Sylvie and Nabbout, Rima and Bar, Claire},
  title = {Intravenous immunoglobulin and febrile status epilepticus in children with Dravet syndrome: A retrospective multicentre study},
  journal = {Developmental Medicine & Child Neurology},
  year = {2025},
  doi = {10.1111/dmcn.70077}
}
Kostenlos starten →